Principle Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$213K Sell
3,392
-33
-1% -$2.64K 0.01% 359
2025
Q4
$327K Buy
3,425
+21
+0.6% +$2.06K 0.02% 299
2025
Q3
$332K Hold
3,404
0.02% 290
2025
Q2
$366K Buy
3,404
+5
+0.1% +$506 0.02% 276
2025
Q1
$343K Hold
3,399
0.02% 268
2024
Q4
$304K Buy
3,399
+25
+0.7% +$2.2K 0.02% 282
2024
Q3
$283K Hold
3,374
0.02% 294
2024
Q2
$260K Hold
3,374
0.02% 291
2024
Q1
$231K Buy
+3,374
New +$217K 0.02% 316
2020
Q3
Sell
-2,590
Closed -$91K 184
2020
Q2
$91K Buy
+2,590
New +$93.3K 0.03% 222

Other funds holding BSX

Principle Wealth Partners's BSX Position: Q1 2026 in Review

Principle Wealth Partners reduced its Boston Scientific (BSX) stake by 0.96% in Q1 2026, selling an estimated $2.64K and leaving 3,392 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #359.

Principle Wealth Partners first reported a position in BSX in Q2 2020 and has held it in 10 quarters since. The position peaked at $366K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Principle Wealth Partners held 3,392 shares of Boston Scientific worth $213K as of Q1 2026.
  • Principle Wealth Partners sold 33 Boston Scientific shares in Q1 2026, an estimated $2.64K.
  • Boston Scientific made up 0.01% of Principle Wealth Partners's portfolio in Q1 2026, its #359 holding.
  • Principle Wealth Partners first reported a position in Boston Scientific in Q2 2020 and has held it in 10 quarters since.
  • Principle Wealth Partners's Boston Scientific position peaked at $366K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Principle Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.